Drug Distribution and Protein Binding Indian Medical PG Practice Questions and MCQs
Practice Indian Medical PG questions for Drug Distribution and Protein Binding. These multiple choice questions (MCQs) cover important concepts and help you prepare for your exams.
Drug Distribution and Protein Binding Indian Medical PG Question 1: Which of the following drugs is least likely to cross the blood-placental barrier?
- A. Atropine
- B. Physostigmine
- C. Hyoscine hydrobromide
- D. Glycopyrrolate (Correct Answer)
Drug Distribution and Protein Binding Explanation: ***Glycopyrrolate***
- Glycopyrrolate is a **quaternary ammonium compound**, meaning it is highly ionized and has a low lipid solubility.
- Its **polar nature** and **larger molecular weight** restrict its ability to readily cross lipid membranes, including the blood-placental barrier.
*Atropine*
- **Atropine** is a tertiary amine, making it a **lipid-soluble** compound.
- Its lipid solubility allows it to **easily cross the blood-placental barrier** and affect the fetus.
*Physostigmine*
- Physostigmine is also a **tertiary amine** and is relatively **lipid-soluble**.
- This property enables it to **readily cross lipid barriers** such as the blood-placental barrier and the blood-brain barrier.
*Hyoscine hydrobromide*
- **Hyoscine hydrobromide** (scopolamine) is a **tertiary amine** and highly **lipid-soluble**.
- Its high lipid solubility allows for its **easy passage across the blood-placental barrier** and into the fetal circulation.
Drug Distribution and Protein Binding Indian Medical PG Question 2: What is the mechanism of metabolism for alcohol, aspirin, and phenytoin at high doses?
- A. First pass kinetics
- B. First order kinetics
- C. Zero order kinetics (Correct Answer)
- D. Second order kinetics
Drug Distribution and Protein Binding Explanation: ***Zero order kinetics***
- This mechanism occurs when the **metabolic enzymes become saturated at high drug concentrations**, leading to a constant amount (not a constant percentage) of drug being eliminated per unit time.
- Alcohol, aspirin, and phenytoin are examples of drugs that exhibit **saturable metabolism**, transitioning from first-order to zero-order kinetics at higher doses.
*First pass kinetics*
- This describes the **metabolism of a drug by the liver or gut wall enzymes before it reaches systemic circulation** after oral administration.
- While relevant to the oral bioavailability of these drugs, it does not describe the specific mechanism of elimination at high doses.
*First order kinetics*
- In this mechanism, a **constant fraction or percentage of the drug is eliminated per unit of time**, meaning the rate of elimination is directly proportional to the drug concentration.
- Most drugs follow first-order kinetics at therapeutic doses because metabolizing enzymes are not saturated.
*Second order kinetics*
- This is a **less common pharmacokinetic model** where the rate of elimination is proportional to the square of the drug concentration or involves two reactants.
- It does not typically describe the common elimination patterns of most drugs, including alcohol, aspirin, and phenytoin.
Drug Distribution and Protein Binding Indian Medical PG Question 3: Choose the correct options regarding the route of administration and bioavailability.
A- Intravenous =1
B- 0.75< Oral <1
C-0.75 <IM ≤ 1
D- 0.75<SC ≤ 1
IM - Intramuscular
SC- Subcutaneous
- A. A and D
- B. A and C
- C. A, C, D (Correct Answer)
- D. A, B, D
Drug Distribution and Protein Binding Explanation: ***A, C, D***
- Intravenous (IV) administration has **100% bioavailability** because the drug enters the systemic circulation directly, bypassing any absorption barriers.
- Intramuscular (IM) and subcutaneous (SC) routes generally have **high bioavailability**, often between 75% and 100%, as drugs are absorbed directly into the bloodstream without first-pass metabolism.
*A and D*
- While options A and D are correct, this choice is incomplete as option C is also a correct statement regarding bioavailability.
- IM administration typically results in high systemic bioavailability, similar to SC, making its exclusion here incorrect.
*A and C*
- While options A and C are correct, this choice is incomplete as option D is also a correct statement regarding bioavailability.
- Subcutaneous administration also generally results in high bioavailability, as absorption tends to be complete.
*A, B, D*
- While options A and D are correct, option B is typically incorrect for oral bioavailability.
- Oral bioavailability of many drugs is often less than 0.75 (75%) due to factors like **first-pass metabolism** and incomplete absorption in the gastrointestinal tract.
Drug Distribution and Protein Binding Indian Medical PG Question 4: A 70 kg man was given a drug with a dose of 100 mg/kg body weight, twice daily. The half-life (t1/2) is 10 hours, the plasma concentration is 1.9 mg/mL, and the clearance is unknown. What is the clearance of this drug?
- A. 20 liter/hr
- B. K is 0.0693
- C. 0.22 L/hr (Correct Answer)
- D. 0.02 L/hr
Drug Distribution and Protein Binding Explanation: ***0.22 L/hr***
- To calculate clearance at steady state, we use the formula: **Clearance (Cl) = Dose Rate / Css** (steady-state plasma concentration).
- **Dose rate calculation**: 100 mg/kg × 70 kg × 2 doses/day = 14,000 mg/day = 583.33 mg/hr
- **Converting plasma concentration**: 1.9 mg/mL = 1900 mg/L
- **Clearance calculation**: Cl = 583.33 mg/hr ÷ 1900 mg/L = **0.307 L/hr**
- **Note**: The calculated value (0.307 L/hr) does not exactly match any option. The marked answer (0.22 L/hr) is the closest approximation among the given choices. This discrepancy may arise from rounding in the original question parameters or implicit assumptions about bioavailability/volume of distribution.
*0.02 L/hr*
- This value is approximately 15 times lower than the calculated clearance.
- Such low clearance would result in much higher plasma concentrations or require significantly lower dosing.
*20 liter/hr*
- This clearance is approximately 65 times higher than calculated, representing an unrealistically high value for this scenario.
- Such high clearance would result in very low plasma concentrations unless extremely high doses were administered.
*K is 0.0693*
- This represents the **elimination rate constant (k)**, calculated as k = 0.693/t1/2 = 0.693/10 hr = 0.0693 hr⁻¹.
- While mathematically correct for k, the question specifically asks for **clearance**, not the elimination rate constant.
- Clearance is related to k by: Cl = k × Vd (volume of distribution).
Drug Distribution and Protein Binding Indian Medical PG Question 5: Major mechanism of transport of drugs across biological membranes is:
- A. Passive diffusion (Correct Answer)
- B. Facilitated diffusion
- C. Active transport
- D. Endocytosis
Drug Distribution and Protein Binding Explanation: ***Passive diffusion***
- This is the **most common mechanism** for drug transport across biological membranes, especially for **lipid-soluble** drugs.
- It occurs down a **concentration gradient** and does not require energy or carrier proteins.
*Facilitated diffusion*
- This process requires **carrier proteins** to move drugs across membranes, but it still occurs down a **concentration gradient** and does not consume energy directly.
- It handles substances that are **too large or too polar** to cross by passive diffusion, but it is not the primary mechanism for most drugs.
*Active transport*
- This mechanism uses **carrier proteins** and **expends energy (ATP)** to move drugs against their **concentration gradient**.
- It is important for the transport of specific drugs, but it is not the predominant mode for the majority of drug molecules.
*Endocytosis*
- This involves the **engulfment of large molecules** or particles by the cell membrane, forming vesicles.
- It is a less common mechanism for drug absorption, primarily used for **very large molecules** like proteins or nanoparticles.
Drug Distribution and Protein Binding Indian Medical PG Question 6: Which of the following is the platinum-based chemotherapeutic agent used as first-line treatment for ovarian carcinoma?
- A. Cyclophosphamide
- B. Methotrexate
- C. Cisplatin (Correct Answer)
- D. Dacarbazine
Drug Distribution and Protein Binding Explanation: ***Cisplatin***
- **Cisplatin** is a platinum-based chemotherapy drug that forms **DNA cross-links**, inhibiting DNA synthesis and leading to the death of rapidly dividing cells, making it highly effective against **ovarian carcinoma**.
- It is a cornerstone of chemotherapy regimens for ovarian cancer, often used in combination with other agents such as paclitaxel.
*Methotrexate*
- **Methotrexate** is an **antimetabolite** that inhibits dihydrofolate reductase, thereby interfering with DNA synthesis.
- While it is used in various cancers like leukemia, lymphoma, and some solid tumors (e.g., breast cancer, gestational trophoblastic disease), it is **not a primary recommended drug for ovarian carcinoma**.
*Cyclophosphamide*
- **Cyclophosphamide** is an **alkylating agent** that causes DNA damage, leading to cell death.
- It is used in many cancers, including lymphoma, breast cancer, and some leukemias, but it is **not a first-line or primary agent for ovarian carcinoma** in contemporary treatment guidelines.
*Dacarbazine*
- **Dacarbazine** is an **alkylating agent** primarily used in the treatment of **malignant melanoma** and Hodgkin lymphoma.
- It is **not indicated for the treatment of ovarian carcinoma**.
Drug Distribution and Protein Binding Indian Medical PG Question 7: Major determinant of loading dose of a drug is:
- A. Half life
- B. Volume of distribution (Correct Answer)
- C. Clearance
- D. Bioavailability
Drug Distribution and Protein Binding Explanation: **Volume of distribution**
- The **loading dose (LD)** of a drug is calculated using the formula: LD = (Target plasma concentration × **Volume of distribution**) / Bioavailability.
- The **volume of distribution (Vd)** is the **major determinant** because it directly determines how much drug is needed to achieve the desired plasma concentration throughout all body compartments.
- A larger Vd means more drug must be administered to achieve the same plasma concentration, as the drug distributes extensively into tissues.
*Half life*
- **Half-life** primarily determines the **time to reach steady-state** and the **dosing interval** for maintenance doses.
- It does not directly influence the initial amount of drug required to achieve a target concentration in the loading dose calculation.
*Clearance*
- **Clearance** is the primary determinant of the **maintenance dose rate**, as it dictates how quickly the drug is eliminated from the body.
- Formula for maintenance dose: Maintenance dose rate = Clearance × Target concentration.
- It is not the major determinant of the initial loading dose, which aims to achieve a therapeutic level quickly.
*Bioavailability*
- **Bioavailability (F)** is the fraction of an administered drug that reaches systemic circulation unchanged.
- While bioavailability is included in the loading dose formula as a correction factor (especially important for oral drugs), the **volume of distribution** remains the **major determinant** as it defines the fundamental space the drug must fill to achieve target concentration.
Drug Distribution and Protein Binding Indian Medical PG Question 8: After IV drug administration, elimination of a drug depends on:
- A. Lipid solubility
- B. Volume of distribution
- C. Clearance (Correct Answer)
- D. All of the options
Drug Distribution and Protein Binding Explanation: ***Clearance***
- **Clearance (CL)** is the primary and direct determinant of drug elimination after IV administration.
- It represents the **volume of plasma cleared of drug per unit time** (e.g., mL/min or L/hr).
- The **rate of elimination** is directly calculated as: Rate = CL × Plasma concentration
- Clearance integrates the efficiency of all eliminating organs (liver, kidneys) and is the key parameter determining how fast a drug is removed from the body.
- Formula: **CL = Rate of elimination / Plasma concentration**
*Lipid solubility*
- Lipid solubility affects drug **distribution** and **renal reabsorption** but does not directly determine the rate of elimination.
- Highly lipid-soluble drugs may be reabsorbed in renal tubules, but the elimination rate is still governed by clearance.
- Lipid solubility is more relevant to drug distribution and metabolism pathways than to the rate of elimination itself.
*Volume of distribution*
- Volume of distribution (Vd) describes how extensively a drug distributes into tissues versus plasma.
- While Vd affects the **half-life** (t½ = 0.693 × Vd/CL), it does NOT directly determine the elimination rate.
- A large Vd means more drug in tissues, which affects how long elimination takes, but the actual rate of elimination is still determined by clearance.
- Vd is a distribution parameter, not an elimination parameter.
*All of the options*
- This is incorrect because only **clearance** directly determines the rate of drug elimination.
- While lipid solubility and volume of distribution can indirectly influence how long a drug remains in the body, they do not determine the elimination rate itself—clearance does.
Drug Distribution and Protein Binding Indian Medical PG Question 9: In a patient with nephrotic syndrome and hypoalbuminemia, the protein binding of which drug will NOT be affected?
- A. Diazepam
- B. Valproate
- C. Tolbutamide
- D. Morphine (Correct Answer)
Drug Distribution and Protein Binding Explanation: ***Morphine***
- Morphine primarily binds to **alpha-1-acid glycoprotein** and has a relatively low affinity for albumin.
- In nephrotic syndrome with **hypoalbuminemia**, the binding of drugs that primarily bind to albumin would be affected, whereas morphine's binding would be largely preserved.
*Diazepam*
- Diazepam is highly protein-bound, primarily to **albumin**.
- In conditions of **hypoalbuminemia**, such as nephrotic syndrome, the unbound fraction of diazepam would increase, potentially leading to altered drug effects.
*Valproate*
- Valproate is extensively protein-bound, predominantly to **albumin**.
- **Hypoalbuminemia** in nephrotic syndrome would lead to a significant decrease in protein binding and an increase in the free, active drug concentration.
*Tolbutamide*
- Tolbutamide is a sulfonylurea that is extensively bound to plasma proteins, mainly **albumin**.
- **Hypoalbuminemia** would decrease its protein binding, increasing the free drug concentration and potentially enhancing its hypoglycemic effect.
Drug Distribution and Protein Binding Indian Medical PG Question 10: Low apparent volume of distribution of drug indicates that:
- A. Drug has low bioavailability
- B. Drug has low efficacy
- C. Drug is not extensively distributed to tissue (Correct Answer)
- D. Drug has low half life
Drug Distribution and Protein Binding Explanation: ***Drug is not extensively distributed to tissue***
- A **low apparent volume of distribution (Vd)** suggests that the drug primarily remains in the **vascular compartment**.
- This indicates **minimal binding to peripheral tissues** and less distribution into extravascular spaces.
*Drug has low bioavailability*
- **Bioavailability** refers to the fraction of an administered drug that reaches the **systemic circulation unchanged**.
- While related to drug disposition, a low Vd does not directly imply low bioavailability; a drug can have high bioavailability but remain largely in the blood.
*Drug has low efficacy*
- **Efficacy** is the maximum effect a drug can produce regardless of the dose.
- Vd relates to drug distribution, not its pharmacological effect or **intrinsic activity** at its target.
*Drug has low half life*
- The **half-life** of a drug is determined by its **volume of distribution (Vd)** and **clearance (CL)** (t½ = 0.693 × Vd / CL).
- While a low Vd can contribute to a shorter half-life if clearance is high, Vd alone does not solely determine half-life; clearance also plays a significant role.
More Drug Distribution and Protein Binding Indian Medical PG questions available in the OnCourse app. Practice MCQs, flashcards, and get detailed explanations.
